Debulking Effect of Curretage on Basal Cell Carcinomas - a Histological Assessment.

The aim of this study was to compare histologically observed tumour infitration of basal cell carcinoma (bcc) lesions before and after curretage.A significant reduction of tumour depth would enable further bcc's included for superficial non-invasive treatment modalities such as topical photodynamic therapy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Carcinoma, Basal Cell Carcinoma Neoplasms Neoplasms by Histologic Type Neoplasms, Basal Cell Neoplasms, Glandular and Epithelial

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

bcc with tumour depth two mm.or more

Exclusion criteria

bcc tumours smaller than three mm in mean diameter.

Treatment and study plan

Curretage

Procedure

Primary outcomes

Reduction of tumour thickness 0,5mm or more after curretage

Time frame: 1 hour

Secondary outcomes

Comparison of tumour thickness in punch biopsies performed on referral, before and after curretage.

Time frame: 3 months

Sponsors and collaborators

Lead sponsor

Norwegian University of Science and Technology

Other

Registry information

Official study title

Relation of Basal Cell Carcinoma Tumour Thickness, Histologically Estimated, in Punch Biopsies Performed Before and After Curretage.

Important dates

Study start: 2002
Primary completion: 2004
Study completion: 2004
First posted: Oct 12, 2005
Registry last updated: Jul 19, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed